Supernus Pharmaceuticals said on Monday the U.S. FDA declined to approve its drug-device combination to treat movement-related symptoms of Parkinson’s disease, sending its shares down 9% in early trade. This is the second time the regulator has refused to approve, dealing a… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]
Published on April 8, 2024
Synchron Inc, a rival to Elon Musk’s Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company’s chief executive told Reuters. Synchron on Monday plans to launch an… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]
Published on April 8, 2024
Un joven de 17 años, con el pelo rubio desgreñado, se subió a la balanza del Centro de Salud Familiar Tri-River de Uxbridge, en Massachusetts. Después que lo pesaran, caminó hacia un consultorio decorado con calcomanías de planetas y personajes de dibujos animados. Una enfermera le tomó la presión arterial. Un pediatra le preguntó por […]
Published on April 7, 2024